French Tech 2030
Lancé en partenariat avec le Secrétariat général pour l’investissement et Bpifrance, le programme French Tech 2030 accompagne pendant deux ans les acteurs émergents qui répondent à de grands enjeux de société, selon les priorités stratégiques du plan France 2030. Les 125 entreprises sélectionnées bénéficient d’un accompagnement financier et extra-financier, coordonné par la Mission French Tech.
French Tech 2030
Amolyt Pharma
Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, … [voir plus]
AQEMIA
Scale Drug Discovery with Quantum-inspired Physics and AI AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative … [voir plus]
Astraveus
We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. [voir plus]
DNA Script
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s … [voir plus]
Enterome
Delivering the promise of immunotherapy Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its unique and powerful bacterial Mimicry drug discovery platform, which allows it to analyze and uncover new biological … [voir plus]
Fabentech
Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be … [voir plus]
Faircraft
Faircraft develops a highly sustainable, lab-grown alternative to animal leather. Faircraft develops a highly sustainable, lab-grown alternative to animal leather, based on advanced tissue engineering and material science techniques. [voir plus]
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, … [voir plus]
Kiro
L'intelligence artificielle au service de la biologie médicale Kiro est une startup en pleine croissance qui développe des solutions d’intelligence artificielle pour la biologie médicale. Nous cherchons à améliorer l'expérience du parcours de soins en fournissant des informations plus compréhensibles aux patients et plus pertinentes aux médecins. Nous pensons que … [voir plus]
LATTICE MEDICAL
Spécialisée en ingénierie tissulaire et en impression 3D, nous développons des implants innovants. Spécialisée en ingénierie tissulaire et en impression 3D, nous développons des implants innovants permettant la régénération des tissus mous grâce à l’utilisation de biomatériaux. Dans la volonté de fournir une meilleure qualité de soins aux patients, Lattice … [voir plus]
Osivax
Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, … [voir plus]
Qubit Pharmaceuticals
Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel … [voir plus]
Resilience
Mieux soigner le cancer Resilience est une entreprise dédiée au suivi à distance et à l’accompagnement des patients en oncologie dont la mission est de mieux soigner le cancer. À travers des outils synergiques destinés aux patient·e·s et à celles et ceux qui les soignent, Resilience apporte une solution globale … [voir plus]
Standing Ovation
Where the wonders of fermentation meet science. Standing Ovation is a French protein company specializing in precision fermentation. The company has developed its first patented ingredient, Advanced Casein®, which is produced with 10 times less CO2, and significantly less water consumption and land use than regular casein, while offering nutritional, … [voir plus]
SWAP Food
Formerly Umiami | The tender, juicy whole filet made from plants. We make delicious, clean-label meat replacements from plants. Our first product, SWAP Filet (SWAP Chicken in the United States) is a thick, whole filet that closely replicates the taste, texture and appearance of chicken using a short list of … [voir plus]
TreeFrog Therapeutics
Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant … [voir plus]
Wandercraft
Ordinary life for Extraordinary people We're hiring ! https://wandercraft.welcomekit.co/ Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia … [voir plus]
WhiteLab Genomics
Unleash the Potential Of Genomic Medicine Using AI Founded in 2019, backed by Y-Combinator, WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines. By leveraging their proprietary technology, WhiteLab Genomics analyzes complex biological data powered by AI to significantly reduce development … [voir plus]